{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:38Z","timestamp":1788416018723,"version":"build-2803163510"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Bilateral adrenal incidentalomas (BAIs) are increasingly detected during abdominal imaging. Their initial clinical, hormonal, and radiological presentation is heterogeneous, and their natural history remains unclear. Current ESE\/ENS@T guidelines lack specific recommendations for BAIs management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective single-center cohort study enrolling 185 consecutive non-operated patients referred between 2009 and 2023 to our endocrinology unit for BAIs (\u226510 mm) with thorough assessment of hormonal, genetic and radiological data. Exclusion criteria were interfering comorbidities or incomplete data. Finally, 120 patients (63 females, mean age = 64.8 \u00b1 8.2) were enrolled. Of these, 64 and 61 patients completed a minimum biochemical and radiological follow-up of 36 months, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At baseline, 56% of patients had mild autonomous cortisol secretion (MACS; 1-mg dexamethasone suppression test [1 mgDST] &amp;gt;1.8 \u00b5g\/dl), and 44% had non-functioning (NF) BAIs. During follow-up, 32.1% of NF patients developed MACS (biochemical progression, BP), while 67.9% remained NF (biochemical stability, BS). Furthermore, 44.3% of patients showed radiological progression (RP) (increase in number and\/or size of nodules \u22653 mm). The BP group had significantly higher baseline 1 mgDST values than the BS group (median: 1.3 vs. 1.1 \u00b5g\/dl,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.025). No other differences were detected between BP versus BS or RP versus radiological stability (RS) groups. In the RP group, only 7.4% of patients also showed BP. Patients with RP &amp;gt;10\u00a0mm (13.1%) had higher baseline 1 mgDST levels (3.5 vs. 2.2 \u00b5g\/dl,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.045).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A non-negligible percentage of BAIs show hormonal and\/or radiological progression. Our findings suggest that BAIs may represent a subgroup warranting individualized clinical reassessment and further prospective multicenter studies to define optimal surveillance strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1912889","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:23:14Z","timestamp":1788412994000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Progression of bilateral adrenal incidentalomas: a monocentric cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Alessandra","family":"Mangone","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan","place":["Milan, Italy"]},{"name":"Endocrinology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pes","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Frigerio","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Renda","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Ferrante","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Peverelli","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan","place":["Milan, Italy"]},{"name":"Endocrinology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan","place":["Milan, Italy"]},{"name":"Endocrinology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Palmieri","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7566","article-title":"Cohort study of patients with adrenal lesions discovered incidentally","volume":"98","author":"Muth","year":"2011","journal-title":"Br J Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2015.1683","article-title":"Differences between bilateral adrenal incidentalomas and unilateral lesions","volume":"150","author":"Pasternak","year":"2015","journal-title":"JAMA Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7326\/M22-1619","article-title":"Prevalence and characteristics of adrenal tumors in an unselected screening population: a cross-sectional study","volume":"175","author":"Jing","year":"2022","journal-title":"Ann Intern Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1179817","article-title":"Predicting morphological and functional variations of benign adrenal incidentalomas in relation to initial characteristics","volume":"14","author":"Parazzoli","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04013.x","article-title":"The functional status of incidentally discovered bilateral adrenal lesions","volume":"75","author":"Androulakis","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1530\/EJE-13-0848","article-title":"Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications","volume":"171","author":"Vassilatou","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03963.x","article-title":"High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management","volume":"74","author":"Vassiliadi","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known Malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1210\/endrev\/bnac034","article-title":"Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia","volume":"44","author":"Bertherat","year":"2023","journal-title":"Endocr Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.19.21342","article-title":"Differences in growth rate on CT of adrenal adenomas and Malignant adrenal nodules","volume":"213","author":"Corwin","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0058","article-title":"Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome","volume":"163","author":"de Groot","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00236-9","article-title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","volume":"9","author":"Chasseloup","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0033","article-title":"High prevalence of smoking in patients with adrenal incidentalomas: causality or case selection","volume":"183","author":"Olsen","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03228-z","article-title":"Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9\u2009\u00b5g\/dL have a higher prevalence of cardiovascular disease than those with values \u22640.9\u2009\u00b5g\/dL","volume":"79","author":"Araujo-Castro","year":"2023","journal-title":"Endocrine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.794197","article-title":"Attenuation value in adrenal incidentalomas: a longitudinal study","volume":"12","author":"Ceccato","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13294","article-title":"Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up","volume":"86","author":"Papanastasiou","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02476-1","article-title":"Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study","volume":"71","author":"Falcetta","year":"2021","journal-title":"Endocrine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-022-00406-6","article-title":"Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas","volume":"22","author":"Araujo-Castro","year":"2023","journal-title":"Hormones (Athens)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0372","article-title":"Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice","volume":"177","author":"Hong","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0299","article-title":"Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study","volume":"160","author":"Fagour","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602459","article-title":"Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas","volume":"92","author":"Bernini","year":"2005","journal-title":"Br J Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1470489","article-title":"Long-term follow-up study of patients with adrenal incidentalomas","volume":"147","author":"Libe","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1055\/a-1079-4915","article-title":"Clinical characteristics and follow-up results of adrenal incidentaloma","volume":"129","author":"Yilmaz","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235509","article-title":"Predictors of tumour growth and autonomous cortisol secretion development during follow-up in non-functioning adrenal incidentalomas","volume":"10","author":"Araujo-Castro","year":"2021","journal-title":"J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01539-y","article-title":"Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas","volume":"44","author":"Araujo-Castro","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0196","article-title":"Natural history of nonfunctioning adrenal incidentalomas: a 10-year longitudinal follow-up study","volume":"10","author":"Podbregar","year":"2021","journal-title":"Endocr Connect"},{"key":"B32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/cen.15109","article-title":"Beyond symptomatology: a comparative analysis of unilateral and bilateral macronodular mild autonomous cortisol secretion","volume":"101","author":"Barlas","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0240","article-title":"Diagnosis and management of primary bilateral macronodular adrenal hyperplasia","volume":"26","author":"Vassiliadi","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(26)00098-7","article-title":"Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study","volume":"14","author":"Suntornlohanakul","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2026.03.005","article-title":"Cardiometabolic risk in bilateral versus unilateral nonfunctioning adrenal incidentalomas: evidence from a large referral center cohort","volume":"32","author":"Febbraro","year":"2026","journal-title":"Endocr Pract"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1912889\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:23:15Z","timestamp":1788412995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1912889\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":35,"alternative-id":["10.3389\/fendo.2026.1912889"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1912889","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1912889"}}